Zealand Pharma A/S
ZLDPF
$75.88
-$7.17-8.63%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.76M | 1.38B | 1.14M | 1.29M | 650.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.76M | 1.38B | 1.14M | 1.29M | 650.60K |
| Cost of Revenue | -- | 62.40K | 57.10K | 58.30K | -975.50K |
| Gross Profit | 7.76M | 1.38B | 1.08M | 1.24M | 1.63M |
| SG&A Expenses | 29.90M | 16.80M | 14.51M | 22.01M | 13.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 26.60M | 3.04M | -448.30K | -- |
| Total Operating Expenses | 80.03M | 114.06M | 58.56M | 57.91M | 51.68M |
| Operating Income | -72.26M | 1.27B | -57.42M | -56.61M | -51.03M |
| Income Before Tax | -57.45M | 1.23B | -47.50M | -41.67M | -39.46M |
| Income Tax Expenses | 5.87M | 81.73M | -194.10K | -82.00K | -202.60K |
| Earnings from Continuing Operations | -63.32M | 1.15B | -47.30M | -41.59M | -39.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.32M | 1.15B | -47.30M | -41.59M | -39.26M |
| EBIT | -72.26M | 1.27B | -57.42M | -56.61M | -51.03M |
| EBITDA | -71.13M | 1.27B | -56.58M | -56.24M | -50.11M |
| EPS Basic | -0.90 | 16.29 | -0.67 | -0.59 | -0.56 |
| Normalized Basic EPS | -0.53 | 10.90 | -0.44 | -0.38 | -0.38 |
| EPS Diluted | -0.90 | 16.06 | -0.67 | -0.59 | -0.56 |
| Normalized Diluted EPS | -0.53 | 10.75 | -0.44 | -0.38 | -0.38 |
| Average Basic Shares Outstanding | 70.30M | 70.73M | 70.60M | 70.74M | 70.66M |
| Average Diluted Shares Outstanding | 70.30M | 71.71M | 70.60M | 70.74M | 70.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |